Magnetic brain zaps aim to tame borderline personality disorder
NCT ID NCT07223619
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether gentle magnetic brain stimulation (TMS) can help people with borderline personality disorder better control their emotions and impulses. Up to 20 participants will receive brain scans, up to 3 TMS sessions, and computer tests over about 3 weeks. The goal is to find the best brain area to target for future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Transcranial Magnetic Stimulation (TMS)
What this could lead to
If it works, this could point toward a new, non-invasive treatment option for borderline personality disorder that helps with emotional control and impulsivity.
What could go wrong
This is a very small pilot study with only 20 people, so results may not apply to everyone. It is early-stage research, and the treatment may not show clear benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BORDERLINE PERSONALITY DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Semel Institute/ UCLA TMS
Los Angeles, California, 90024, United States